A New Approach for Preparing Stable High-Concentration Peptide Nanoparticle Formulations.

Journal: Pharmaceuticals (Basel, Switzerland)
Published Date:

Abstract

The subcutaneous administration of therapeutic peptides would provide significant benefits to patients. However, subcutaneous injections are limited in dosing volume, potentially resulting in high peptide concentrations that can incur significant challenges with solubility limitations, high viscosity, and stability liabilities. Herein, we report on the discovery that low-shear resonant acoustic mixing can be used as a general method to prepare stable nanoparticles of a number of peptides of diverse molecular weights and structures in water without the need for extensive amounts of organic solvents or lipid excipients. This approach avoids the stability issues observed with typical high-shear, high-intensity milling methods. The resultant peptide nanosuspensions exhibit low viscosity even at high concentrations of >100 mg/mL while remaining chemically and physically stable. An example nanosuspension of cyclosporine nanoparticles was dosed in rats via a subcutaneous injection and exhibited sustained release behavior. This suggests that peptide nanosuspension formulations can be one approach to overcome the challenges with high-concentration peptide formulations.

Authors

  • Chloe Hu
    Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Nanzhi Zang
    Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Yu Tong Tam
    Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 940802, USA.
  • Desmond Dizon
    Device Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Kaylee Lee
    Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Jodie Pang
    Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Elizabeth Torres
    Development Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Yusi Cui
    Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Chun-Wan Yen
    Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Dennis H Leung
    Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

Keywords

No keywords available for this article.